GlassScriptPhysician profile
Oliver T Wang
NPI 1063516409
$10,218.39
in general payments reported to CMS, 2019-2025
20 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2021: $118 · 2022: $185 · 2023: $302 · 2024: $8,896 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $8,640 · Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $8,640.00 |
| Food and Beverage | $891.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $8,640.00 | 2024 | |
| Paragon 28, INC. | $285.33 | 2023-2025 | Bun-Yo-Matic, Portfolio, Phantom Metatarsal Shortening |
| Smith+Nephew, INC. | $262.80 | 2019-2024 | Collagenase Santyl |
| Stryker Corporation | $202.13 | 2022-2023 | Salvation, Augment Injectable, Citrefix |
| Arthrex, INC. | $134.68 | 2019 | |
| Amgen INC. | $121.84 | 2024 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $68.67 | 2024-2025 | |
| Bioventus LLC | $66.21 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Linvatec Corporation | $59.38 | 2023 | Colink 2 |
| Conmed Corporation | $56.46 | 2023 | 5ms |
| Organogenesis INC. | $55.31 | 2021-2025 | Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $45.76 | 2024-2025 | Nuzyra |
| Alfasigma USA, INC. | $44.47 | 2021 | |
| Depuy Synthes Sales INC. | $40.20 | 2025 | |
| Saxum Surgical, INC. | $33.65 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $29.84 | 2024 | Miro3d |
| Averitas Pharma INC. | $25.90 | 2025 | Qutenza |
| Abbvie INC. | $23.06 | 2021 | |
| Heron Therapeutics, INC. | $17.69 | 2021 | |
| Orthofix Medical, INC. | $5.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.